Related Experiment Video
Updated: Jul 12, 2025

A Human Fallopian Tube Model for Investigation of C. trachomatis Infections
Published on: August 11, 2012
Interferon-ε as potential inhibitor of Chlamydia trachomatis infection
Simone Filardo1, Marisa Di Pietro1, Giuseppina Bozzuto2
1Department of Public Health and Infectious Diseases, Section of Microbiology, Sapienza University, P.le Aldo Moro, 5, 00185, Rome, Italy.
Abstract:
Chlamydia trachomatis, the main cause of bacterial sexually transmitted diseases, is responsible for severe reproductive sequelae. Amongst all the cytokines involved in host immunity towards this pathogen, IFN-ε has recently acquired importance for its potential contribution to the female reproductive tract innate defenses. Herein, our study aimed to explore, for the first time, the activity of IFN-ε toward C. trachomatis in an in vitro infection model, by testing its effects on the different phases of chlamydial developmental cycle, as well as on the ultrastructural characteristics of chlamydial inclusions, via transmission electron microscopy. Main result is the capability of IFN-ε to alter C. trachomatis growth, as suggested by reduced infectious progenies, as well as a patchy distribution of bacteria and altered morphology of reticulate bodies within inclusions. In conclusion, our results suggest that IFN-ε could play a role in the innate and adaptive immune defenses against C. trachomatis; in the future, it will be needed to investigate its activity on an infection model more closely resembling the physiological environment of the female genital tract.
Related Concept Videos
Bacterial Phylum Chlamydiae
Sexually Transmitted Infections
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...

